辅助生殖技术治疗中常见并发症的危害

doi:10.6040/j.issn.1671-7554.0.2019.724

摘要/Abstract

摘要： 随着辅助生殖技术(ART)的迅猛发展、日趋成熟,其伴随的风险与挑战也不容忽视。ART中常见并发症包括卵巢过度刺激综合征、附件扭转、取卵后出血、感染、器官损伤、多胎妊娠、异位妊娠等,这些并发症不仅影响妊娠结局,还可能影响生活质量甚至生命健康,故ART中的风险与安全管理尤为重要。应制定标准化质量管理体系,提前识别并发症危险因素、设置有效预防措施、及时发现异常、准确诊断并个体化治疗,使ART可获得更加令人满意的效果与收益。

关键词: 辅助生殖技术, 并发症, 危害, 风险与安全管理

Abstract: With the rapid development of assisted reproductive technology(ART), the risks and challenges accompanied cannot be ignored. Ovarian hyperstimulation syndrome, adnexal torsion, hemorrhage after oocyte retrieval, infection, organ damage, multiple pregnancy, and ectopic pregnancy are the common complications of ART. These complications may adversely affect pregnancy outcomes, having an impact on health-related quality of life or even being life-threatened. Serious concern is warranted in terms of risk factors and safety management of ART. Establishing standardized quality management system to identify risk factors in advance, taking effective prevention measures, identifying anomalies in time and providing individualized treatment will make ART more satisfactory.

Key words: Assisted reproductive technology, Complications, Hazards, Risk and safety management

中图分类号:

R711.6

郝桂敏,罗卓野,崔娜. 辅助生殖技术治疗中常见并发症的危害[J]. 山东大学学报 (医学版), 2019, 57(10): 7-12.

HAO Guimin, LUO Zhuoye, CUI Na. Hazards of common complications in assisted reproductive technology[J]. Journal of Shandong University (Health Sciences), 2019, 57(10): 7-12.

参考文献

[1] 庄广伦. 必须重视辅助生殖技术可能风险的防治[J]. 国际生殖健康/计划生育杂志, 2011, 30(4): 263-264. ZHUANG Guanglun. Assisted reproductive techniques and its potential risks[J]. J Int Reprod Health/Fam Plan,2011, 30(4): 263-264.
[2] Practice Committee of the American Society for Reproductive Medicine. Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline[J]. Fertil Steril, 2016, 106(7): 1634-1647.
[3] Timmons D, Montrief T, Koyfman A, et al. Ovarian hyperstimulation syndrome: a review for emergency clinicians [J]. Am J Emerg Med, 2019. [Epub ahead of print]
[4] Royal College of Obstetricians and Gynaecologists. The Management of Ovarian Hyperstimulation Syndrome: Green-top Guideline No. 5 [J/OL]. 26/02/2016.https://www.rcog.org.uk
[5] 中华医学会生殖医学分会. 辅助生殖技术并发症诊断及处理共识[J]. 生殖与避孕, 2015, 35(7): 431-439.
[6] Mashiach S, Bider D, Moran O, et al. Adnexal torsion of hyperstimulated ovaries in pregnancies after gonadotropin therapy [J]. Fertil Steril, 1990, 53(1): 76-80.
[7] Rova K, Passmark H, Lindqvist PG. Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles [J]. Fertil Steril, 2012, 97(1): 95-100.
[8] Courbiere B, Oborski V, Braunstein D, et al. Obstetric outcome of women with in vitro fertilization pregnancies hospitalized for ovarian hyperstimulation syndrome: a case-control study [J]. Fertil Steril, 2011, 95(5): 1629-1632.
[9] Hilbert SM, Gunderson S. Complications of assisted reproductive technology [J]. Emerg Med Clin North Am, 2019, 37(2): 239-249.
[10] Kives S, Gascon S, Dubuc É, et al. No. 341-Diagnosis and management of adnexal torsion in children, adolescents, and Adults [J]. J Obstet Gynaecol Can, 2017, 39(2): 82-90.
[11] Kaya C, Turgut H, Cengiz H, et al. Effect of detorsion alone and in combination with enoxaparin therapy on ovarian reserve and serum antimüllerian hormone levels in a rat ovarian torsion model [J]. Fertil Steril, 2014, 102(3): 878-884.
[12] Yasa C, Dural O, Bastu E, et al. Impact of laparoscopic ovarian detorsion on ovarian reserve [J]. J Obstets Gynaecol Res, 2017, 43(2): 298-302.
[13] Oskayli M, Gulcin N, Ozatman E, et al. Assessment of ovarian reserve by serum AMH levels after ovarian torsion surgery [J]. Pediatr Int, 2019, 61(5): 504-507.
[14] Grandone E, Di Micco P, Villani M, et al. Venous thromboembolism in women undergoing assisted reproductive technologies: data from the RIETE registry [J]. Thromb Haemos, 2018, 118(11): 1962-1968.
[15] Hansen AT, Kesmodel US, Juul S, et al. Increased venous thrombosis incidence in pregnancies after in vitro fertilization [J]. Hum Reprod, 2014, 29(3): 611-617.
[16] Kasum M, Danolic D, OresKovic S, et al. Thrombosis following ovarian hyperstimulation syndrome [J]. Gynecological Endocrinology, 2014, 30(11): 764-768.
[17] 中华医学会呼吸病学分会肺栓塞与肺血管病学组, 中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会, 全国肺栓塞与肺血管病防治协作组. 肺血栓栓塞症诊治与预防指南[J]. 中华医学杂志, 2018, 98(1): 1060-1087.
[18] Nelson, Scott M. Venous thrombosis during assisted reproduction: novel risk reduction strategies [J]. Thrombosis Research, 2013, 131(suppl_S1): S1-S3.
[19] Levi-Setti PE, Cirillo F, Scolaro V, et al. Appraisal of clinical complications after 23 827 oocyte retrievals in a large assisted reproductive technology program [J]. Fertil Steril, 2018, 109(6): 1038-1043.
[20] Siristatidis C, Chrelias C, Alexiou A, et al. Clinical complications after transvaginal oocyte retrieval: a retrospective analysis [J]. J Obstet Gynaecol, 2013, 33(1): 64-66.
[21] Nouri K, Walch K, Promberger R, et al. Severe haematoperitoneum caused by ovarian bleeding after transvaginal oocyte retrieval: a retrospective analysis and systematic literature review [J]. Reprod Biomed Online, 2014, 29(6): 699-707.
[22] Dessole S, Rubattu G, Ambrosini G, et al. Blood loss following noncomplicated transvaginal oocyte retrieval for in vitro fertilization [J]. Fertil Steril, 2001, 76(1): 205-206.
[23] De Ziegler D, Gambone JC, Meldrum DR, et al. Risk and safety management in infertility and assisted reproductive technology(ART): from the doctors office to the ART procedure [J]. Fertil Steril, 2013, 100(6): 1509-1517.
[24] Aragona C, Mohamed MA, Espinola MS, et al. Clinical complications after transvaginal oocyte retrieval in 7,098 IVF cycles[J]. Fertil Steril, 2011, 95(1): 293-294.
[25] Villette C, Bourret A, Santulli P, et al. Risks of tubo-ovarian abscess in cases of endometrioma and assisted reproductive technologies are both under- and overreported [J]. Fertil Steril, 2016, 106(2): 410-415.
[26] El-Toukhy T, Hanna L. Pelvic infection after oocyte retrieval: a preventable complication or an inevitable risk? [J]. J Obstet Gynaecol, 2006, 26: 701-703.
[27] Moini A, Riazi K, Amid V, et al. Endometriosis may contribute to oocyte retrieval-induced pelvic inflammatory disease: report of eight cases [J]. J Assist Reprod Genet, 2005, 22(7-8): 307-309.
[28] Brunham RC, Gottlieb SL, Paavonen J. Pelvic inflammatory disease [J]. N Engl J Med, 2015, 372(21): 2039-2048.
[29] Souza MDCB, Souza MM, Antunes RA, et al. Bladder hematoma: a complication from an oocyte retrieval procedure [J]. JBRA Assist Reprod, 2019, 23(1): 75-78.
[30] Catanzarite T, Bernardi LA, Confino E, et al. Ureteral trauma during transvaginal ultrasound-guided oocyte retrieval: a case report [J]. Female Pelvic Med Reconstr Surg, 2015, 21(5): 44-45.
[31] Spencer ES, Hoff HS, Steiner AZ, et al. Immediate ureterovaginal fistula following oocyte retrieval: a case and systematic review of the literature[J]. Urol Ann, 2017, 9(2): 125-130.
[32] Modder J, Kettel LM, Sakamoto K. et al. Hematuria and clot retention after transvaginal oocyte aspiration: a case report [J]. Fertil Steril, 2006, 86(3): 720.e1-2.
[33] Committee on Practice Bulletins—Obstetrics. Practice Bulletin No. 169: Multifetal Gestations: Twin, Triplet, and Higher-Order Multifetal Pregnancies [J]. Obstet Gynecol, 2016, 128(4): 131-146.
[34] Martin AS, Chang J, Zhang Y, et al. Perinatal outcomes among singletons after assisted reproductive technology with single-embryo or double-embryo transfer versus no assisted reproductive technology [J]. Fertil Steril, 2017, 107(4): 954.
[35] European IVF-monitoring Consortium(EIM), European Society of Human Reproduction and Embryology(ESHRE), Calhaz-Jorge C, et al. Assisted reproductive technology in Europe, 2013: results generated from European registers by ESHRE [J]. Hum Reprod, 2017, 32(10): 1957-1973.
[36] Santana DS, Cecatti JG, Surita FG, et al. Twin pregnancy and severe maternal outcomes: the world health organization multicountry survey on maternal and newborn health [J]. Obstet Gynecol, 2016, 127: 631-641.
[37] Pinborg A. IVF/ICSI twin pregnancies: risks and prevention [J]. Hum Reprod Update, 2005, 11: 575-593.
[38] 中华医学会生殖医学分会. 多胎妊娠减胎术操作规范(2016)[J]. 生殖医学杂志, 2017, 26(3): 6-11.
[39] 中华医学会生殖医学分会. 关于胚胎移植数目的中国专家共识[J]. 生殖医学杂志, 2018, 27(10): 21-26.
[40] National Center for Chronic Disease Prevention and Health Promotion, Division of Reproductive Health. Assisted reproductive technology, National Summary Report [R]. https://www. cdc.gov/art/ pdf/2016-report/ ART- 2016- National-Summary-Report.pdf.
[41] Warda H, Mamik MM, Ashraf M, et al. Interstitial ectopic pregnancy: conservative surgical management [J]. JSLS, 2014, 18(2): 197-203.
[42] Skiadas CC, Missmer SA, Benson CB, et al. Impact of selective reduction of the monochorionic pair in vitro fertilization triplet pregnancies on gestational length [J]. Fertil Steril, 2010, 94(7): 2930-2931.
[43] Garcia-Alix GA, Anette L, Steen S, et al. Serum anti-Müllerian hormone concentration before and after salpingectomy for ectopic pregnancy [J]. Reprod BioMed Online, 2018, 37(5): 624-630.
[44] Fernandez H, Capmas P, Lucot JP, et al. Fertility after ectopic pregnancy: the DEMETER randomized trial [J]. Hum Reprod, 2013, 28(5): 1247-1253.
[45] Cheng X, Tian X, Yan Z, et al. Comparison of the fertility outcome of salpingotomy and salpingectomy in women with tubal pregnancy: a systematic review and meta-analysis [J]. PLoS One, 2016, 11(3): e0152343.
[46] Xiao S, Mo M, Hu X, et al. Study on the incidence and influences on heterotopic pregnancy from embryo transfer of fresh cycles and frozen-thawed cycles [J]. J Assist Reprod Genet, 2018, 35(1437): 1-5.
[47] Yu Y, Xu W, Xie Z, et al. Management and outcome of 25 heterotopic pregnancies in Zhejiang, China [J]. Eur J Obstet Gynecol Reprod Biol, 2014, 80: 157-161. doi: 10.1016/j.ejogrb.2014.04.046.
[48] 石玉华, 陈子江. 辅助生殖技术子代体格和精神健康[J]. 中国实用妇科与产科杂志, 2018, 34(6): 26-29. SHI Yuhua,CHEN Zijiang. General health and mental health of offspring after assisted reproductive technology[J]. Chinese Jourmal of Practical Gynecology and Obstetri, 2018, 34(6): 26-29.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed